Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatment
Pallav L. Shah(Guy's and St Thomas' NHS Foundation Trust), al et(Université Ibn-Tofail), SF Scott(Royal Brompton Hospital), DE Tullis(Wellesley Institute), GJ Canny(Royal Brompton Hospital), H J Fuchs(Boston Children's Hospital), MC Light(Royal Brompton Hospital), C.L. Johnson(Royal Brompton Hospital), Andrew Bush(British Lung Foundation), DM Geddes(Royal Brompton Hospital), AA Colin(Boston Children's Hospital)
Cited by 88
Related Papers
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force
|European Respiratory Journal|1995|1.6k
Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma: A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Trial
|American Journal of Respiratory and Critical Care Medicine|2009|686
Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks
|Nature Genetics|2017|591
Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children
|European Respiratory Journal|2009|520